Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group.
Fountzilas E, Lampaki S, Koliou GA, Koumarianou A, Levva S, Vagionas A, Christopoulou A, Laloysis A, Psyrri A, Binas I, Mountzios G, Kentepozidis N, Kotsakis A, Saloustros E, Boutis A, Nikolaidi A, Fountzilas G, Georgoulias V, Chrysanthidis M, Kotteas E, Vo H, Tsiatas M, Res E, Linardou H, Daoussis D, Bompolaki I, Andreadou A, Papaxoinis G, Spyratos D, Gogas H, Syrigos KN, Bafaloukos D. Fountzilas E, et al. Among authors: papaxoinis g. Cancer Immunol Immunother. 2022 Feb;71(2):327-337. doi: 10.1007/s00262-021-02985-6. Epub 2021 Jun 23. Cancer Immunol Immunother. 2022. PMID: 34164709 Free PMC article.
Cisplatin-based chemotherapy for merkel cell carcinoma of the skin.
Pectasides D, Pectasides M, Psyrri A, Koumarianou A, Xiros N, Pectasides E, Gaglia A, Lianos E, Papaxoinis G, Lampadiari V, Economopoulos T. Pectasides D, et al. Among authors: papaxoinis g. Cancer Invest. 2006 Dec;24(8):780-5. doi: 10.1080/07357900601062354. Cancer Invest. 2006. PMID: 17162559
Gemcitabine and pegylated liposomal doxorubicin alternating with cisplatin plus cyclophosphamide in platinum refractory/resistant, paclitaxel-pretreated, ovarian carcinoma.
Pectasides D, Xiros N, Papaxoinis G, Aravantinos G, Sykiotis C, Pectasides E, Psyrri A, Koumarianou A, Gaglia A, Gouveris P, Economopoulos T. Pectasides D, et al. Among authors: papaxoinis g. Gynecol Oncol. 2008 Jan;108(1):47-52. doi: 10.1016/j.ygyno.2007.08.061. Epub 2007 Oct 25. Gynecol Oncol. 2008. PMID: 17915300 Clinical Trial.
Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.
Pectasides D, Xiros N, Papaxoinis G, Pectasides E, Sykiotis C, Koumarianou A, Psyrri A, Gaglia A, Kassanos D, Gouveris P, Panayiotidis J, Fountzilas G, Economopoulos T. Pectasides D, et al. Among authors: papaxoinis g. Gynecol Oncol. 2008 May;109(2):250-4. doi: 10.1016/j.ygyno.2008.01.028. Epub 2008 Mar 4. Gynecol Oncol. 2008. PMID: 18299146
Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG).
Pectasides D, Papaxoinis G, Fountzilas G, Aravantinos G, Bamias A, Pavlidis N, Kalofonos HP, Timotheadou E, Samantas E, Briasoulis E, Skarlos DV, Economopoulos T, Dimopoulos MA; Hellenic Cooperative Oncology Group. Pectasides D, et al. Among authors: papaxoinis g. Anticancer Res. 2009 Feb;29(2):745-51. Anticancer Res. 2009. PMID: 19331231 Free article.
88 results